D. H. Cowan

525 total citations
32 papers, 415 citations indexed

About

D. H. Cowan is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, D. H. Cowan has authored 32 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 9 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in D. H. Cowan's work include Acute Myeloid Leukemia Research (7 papers), Acute Lymphoblastic Leukemia research (5 papers) and Chronic Lymphocytic Leukemia Research (3 papers). D. H. Cowan is often cited by papers focused on Acute Myeloid Leukemia Research (7 papers), Acute Lymphoblastic Leukemia research (5 papers) and Chronic Lymphocytic Leukemia Research (3 papers). D. H. Cowan collaborates with scholars based in Canada, Brazil and United States. D. H. Cowan's co-authors include R. Hasselback, Daniel E. Bergsagel, Adel G. Fam, E. A. McCulloch, W. Pruzanski, Joel D. Rubenstein, Abdelsalam H. Ragab, Barbara E. Hazlett, Kathleen I. Pritchard and J. E. Curtis and has published in prestigious journals such as The Lancet, Blood and Diabetes.

In The Last Decade

D. H. Cowan

31 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. H. Cowan Canada 12 186 118 100 67 61 32 415
Debra Frei‐Lahr United States 9 192 1.0× 128 1.1× 115 1.1× 128 1.9× 88 1.4× 18 487
Robert C. Neerhout United States 14 127 0.7× 147 1.2× 90 0.9× 145 2.2× 77 1.3× 34 619
Michio Matsuzaki Japan 11 280 1.5× 101 0.9× 90 0.9× 129 1.9× 110 1.8× 29 578
HM Lazarus United States 6 305 1.6× 143 1.2× 89 0.9× 71 1.1× 68 1.1× 7 461
Mirando Mršić Croatia 15 171 0.9× 139 1.2× 82 0.8× 39 0.6× 48 0.8× 41 562
MC Poon Canada 13 362 1.9× 88 0.7× 54 0.5× 50 0.7× 129 2.1× 26 482
C B Freeman United States 12 101 0.5× 146 1.2× 70 0.7× 151 2.3× 83 1.4× 20 433
D Samson United Kingdom 12 372 2.0× 115 1.0× 81 0.8× 50 0.7× 159 2.6× 23 560
Cooper Mr United States 10 230 1.2× 161 1.4× 115 1.1× 29 0.4× 78 1.3× 27 494
SJ Forman United States 8 413 2.2× 116 1.0× 57 0.6× 100 1.5× 70 1.1× 8 517

Countries citing papers authored by D. H. Cowan

Since Specialization
Citations

This map shows the geographic impact of D. H. Cowan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. H. Cowan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. H. Cowan more than expected).

Fields of papers citing papers by D. H. Cowan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. H. Cowan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. H. Cowan. The network helps show where D. H. Cowan may publish in the future.

Co-authorship network of co-authors of D. H. Cowan

This figure shows the co-authorship network connecting the top 25 collaborators of D. H. Cowan. A scholar is included among the top collaborators of D. H. Cowan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. H. Cowan. D. H. Cowan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cowan, D. H.. (2011). O. Harold Warwick: Canada’s First Medical Oncologist. Current Oncology. 18(3). 117–120.
2.
Cowan, D. H.. (2010). Vera Peters and the Conservative Management of Early-Stage Breast Cancer. Current Oncology. 17(2). 50–54. 1 indexed citations
3.
MacKenzie, Robert G., E. Franssen, Rebecca Wong, et al.. (2000). Risk-Adapted Therapy for Clinical Stage I–II Hodgkin's Disease: 7-Year Results of Radiotherapy Alone for Low-Risk Disease, and ABVD and Radiotherapy for High-Risk Disease. Clinical Oncology. 12(5). 278–288. 4 indexed citations
4.
Cowan, D. H., et al.. (1994). Spontaneous remission of polycythemia vera: Clinical and cell culture characteristics. American Journal of Hematology. 46(1). 54–56. 5 indexed citations
5.
Friedman, Steven, et al.. (1992). Progress and survival factors in acute non lymphocytic leukemia. A 15 year analysis.. PubMed. 34(3). 233–7. 1 indexed citations
6.
Rudinskas, Leona, et al.. (1989). Poor clinical response to enteric-coated iron preparations.. PubMed. 141(6). 565–6. 11 indexed citations
7.
Shumak, Steven L., et al.. (1988). Hodgkin's disease complicating non-Hodgkin's lymphoma.. PubMed. 139(12). 1157–9. 2 indexed citations
8.
Shumak, Steven L., Sarah D. McDonald, Paul N. Baer, & D. H. Cowan. (1987). Erysipelothrix septicemia in an immunocompromised host.. PubMed. 136(3). 273–4. 7 indexed citations
9.
Fam, Adel G., Joel D. Rubenstein, & D. H. Cowan. (1986). Poems syndrome. Study of a patient with proteinuria, microangiopathic glomerulopathy, and renal enlargement. Arthritis & Rheumatism. 29(2). 233–241. 32 indexed citations
10.
Pinkerton, Peter H., et al.. (1985). Low dose cytosine arabinoside in acute myeloid leukemia: Remission is not due to differentiation induction. American Journal of Hematology. 19(4). 415–417. 10 indexed citations
11.
Fam, Adel G., Arthur J. Lewis, & D. H. Cowan. (1982). Multiple myeloma and amyloid bone lesions complicating rheumatoid arthritis.. PubMed. 8(5). 845–50. 12 indexed citations
12.
Cowan, D. H., et al.. (1977). Alteration of Platelet Cyclic AMP (cAMP) by Ethanol. Thrombosis and Haemostasis. 3 indexed citations
13.
Pritchard, Kathleen I., D. H. Cowan, Michael A. Baker, et al.. (1976). The use of oral BCG in the treatment of metastatic malignant melanoma. Medical and Pediatric Oncology. 2(2). 173–181. 4 indexed citations
14.
Cowan, D. H., et al.. (1975). Occurrence of hepatitis and hepatitis B surface antigen in adult patients with acute leukemia.. PubMed. 112(6). 693–7. 11 indexed citations
15.
Pruzanski, W., et al.. (1974). Clinical and immunochemical studies of IgM cold agglutinins with lambda type light chains. Clinical Immunology and Immunopathology. 2(2). 234–245. 29 indexed citations
16.
Cowan, D. H., H. A. Messner, John S. Senn, & E. A. McCulloch. (1973). The Heterogeneity of Cell Culture Findings in Patients with Acute Myeloblastic Leukemia. PubMed. 43. 92–96. 1 indexed citations
17.
Ragab, A H & D. H. Cowan. (1973). Separation of cells involved in the mixed leukocyte culture by velocity sedimentation. Cellular Immunology. 7(2). 336–340. 3 indexed citations
18.
Ragab, Abdelsalam H., Barbara E. Hazlett, & D. H. Cowan. (1972). Response of Peripheral Blood Lymphocytes from Patients with Diabetes Mellitus to Phytohemagglutinin and Candida Albicans Antigen. Diabetes. 21(8). 906–907. 30 indexed citations
19.
Bergsagel, Daniel E., D. H. Cowan, & R. Hasselback. (1972). Plasma cell myeloma: response of melphalan-resistant patients to high-dose intermittent cyclophosphamide.. PubMed. 107(9). 851–5. 65 indexed citations
20.
Abu-Zahra, Hakam, Albert Clarysse, D. H. Cowan, R. Hasselback, & Daniel E. Bergsagel. (1972). Treatment of acute myeloblastic leukemia in adults: remission induction with a combination of cyclophosphamide, cytarabine and vincristine.. PubMed. 107(11). 1073–8. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026